Results are reported of long-term anticoagulant treatment in a group of 90 patients with rheumatic heart disease who had systemic embolism. Compared to the reported incidence of recurrent systemic embolism in patients not given anticoagulant drugs, such therapy remarkably lowers the risk of such occurrences. Complications from this treatment in the reported patients were minimal.
Misra, Sudarsan and Schatz, Irwin J.
"Prevention of Recurrent Systemic Embolism with Anticoagulants in Patients with Rheumatic Heart Disease,"
Henry Ford Hospital Medical Journal
: Vol. 19
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol19/iss3/3